Kuo, M.D., M.B.A., Adeona's CEO. We achieved these medical milestones while also increasing our revenues from several sources and thoroughly managing our operating expenditures. Dr. Kuo added, With the addition of the net arises from the financing in January of 2011, we believe our current money position should match our planned operating needs for at least another 12 months. .. Adeona reports $3,164,512 net revenue for 2010 2010 Adeona Pharmaceuticals, Inc. , a programmer of innovative medications for serious central nervous system diseases, reported its financial outcomes for the entire year ended December 31, 2010, and also updates since the start of the 4th quarter.Related StoriesCornell biomedical engineers develop 'super organic killer cells' to destroy malignancy cells in lymph nodesNew antenna-like device makes breasts cancer surgery much easier for surgeonsSausages With Antioxidants From Berries TO AVOID CancerThey’re working with cancer researchers Alexander Borowsky, Robert Cardiff and Jeffrey Gregg at the UC Davis Center for Comparative Medication to review cancerous growths in mice equivalent to ductal carcinoma in situ , a precursor to breast malignancy in humans. With non-invasive imaging, the development can be followed by us of disease in one mouse over a long time period, Abbey said.